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In 2002, the International Agency for Research on Cancer
Handbook on Weight Control and Physical Activity concluded
that overweight and obesity are related to cancers of the colon,
endometrium, kidney and oesophagus (adenocarcinomas), as well
as postmenopausal breast cancer. Since that report, continuing
epidemiological investigation has suggested that other cancers are
related to obesity and overweight. In addition to those listed above,
the report by the World Cancer Research Fund (WCRF) Panel on
Food, Nutrition, Physical Activity, and the Prevention of Cancer
(WCRF, 2007) considered that there was convincing evidence for
an association with cancers of the pancreas and rectum (as well as
colon), and a probable association with cancers of the gall bladder.
The fraction of these cancers occurring in 2010 attributable to
overweight and obesity in the UK population is estimated in this
section.
METHODS
The estimates of risk associated with overweight (BMI
25o30kgm
 2) and obesity (BMI 30þ kgm
 2), relative to a
BMIp25kgm
 2, for the seven cancers, are shown in Table 1. The
estimates of relative risk for an increase of 5kgm
 2 from the meta-
analyses by WCRF (2007) have been used for the category
‘overweight’. Assuming a constant rate of increase in risk with
BMI, the square of this value was taken for the category ‘obese’.
For postmenopausal breast cancer, WCRF reported that the
increase in risk was 8% per BMI increase of 5kgm
 2 for cohort
studies (17 considered) and 13% per BMI increase of 5kgm
 2 for
case–control studies (48 considered). The estimates from the
meta-analyses of Bergstrom et al (2001) and Renehan et al (2008)
were almost identical (12% per BMI increase of 5kgm
 2), and thus
this value has been selected.
The latent period, or interval between ‘exposure’ to overweight/
obesity and the appropriate increase in risk of these cancers, is
not known. Renehan et al (2008) calculated the geometric mean
duration of follow-up in the cohort studies available for a meta-
analysis of relative risks due to overweight and obesity. The
periods ranged from 8.4 years (for breast cancer) to 12.7 years (for
gall bladder cancer). We therefore chose to assume that the latency
between ‘exposure’ and outcome would be, on average, 10 years,
and thus examine the effects on cancers occurring in 2010
from suboptimal levels of body mass in 2000. The proportion of
adults in the age group of 19–64 who were overweight or obese in
Great Britain in 2000–2001 is available from the National Diet and
Nutrition Survey (FSA, 2004; Table 4.1). For older adults (aged
X65), we used the values for 2000 from the Health Survey for
England (Health and Social Care Information Centre, 2010). The
results are shown in Table 2.
Table 1 Relative risks associated with overweight and obesity
Relative risks Excess relative risks
Cancer (site) Overweight Obese Overweight Obese
Breast (post-menopausal)
a,b 1.12 1.25 0.12 0.25
Colorectum
c 1.15 1.32 0.15 0.32
Oesophagus (adenocarcinoma)
c 1.55 2.40 0.55 1.40
Kidney
c 1.31 1.72 0.31 0.72
Endometrium
c 1.52 2.31 0.52 1.31
Gall bladder
c 1.23 1.51 0.23 0.51
Pancreas
c 1.14 1.30 0.14 0.30
aFrom Bergstrom et al (2001).
bFrom Renehan et al (2008).
cFrom WCRF (2007).
Table 2 Prevalence of overweight and obesity in Great Britain in
2000–2001
Prevalence of overweight and
obesity by age group (years)
BMI 19–24
a 25–34
a 35–49
a 50–64
a 65–74
b X75
b
Men
25o30 (overweight) 0.25 0.42 0.45 0.46 0.50 0.52
X30 (obese) 0.18 0.18 0.25 0.32 0.24 0.17
Women
25o30 (overweight) 0.25 0.28 0.31 0.41 0.41 0.41
X30 (obese) 0.14 0.16 0.23 0.22 0.30 0.23
Abbreviations: BMI¼body mass index.
aFrom the National Diet and Nutrition Survey
(ages 19–64).
bFrom Health Survey for England (ages 465). *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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partitioned by histological subtype, according to the age- and
sex-specific distribution observed in the UK Cancer registries
reporting to Cancer Incidence in Five Continents, Volume VIII
(Parkin et al, 2002). These age-specific proportions were scaled
to correspond to the crude proportions observed in the UK
registries in 2000–2002 (Curado et al, 2007), when adenocarcino-
mas comprised 69.9% of oesophageal cancers in men and 39.9% in
women.
The population-attributable fraction (PAF) was calculated for
each sex–age group, corresponding to the level of overweight/
obesity 10 years previously, according to the usual formula:
PAF ¼
ðp1 ERR1Þþð p2 ERR2Þ
1 þ½ ð p1 ERR1Þþð p2 ERR2Þ 
where p1 is the proportion of population overweight, p2 the
proportion of population obese, ERR1 the excess relative risk
(RR 1) for overweight and ERR2 the excess relative risk (RR 1)
for obesity.
RESULTS
Table 3 shows the calculation of attributable fractions, and
corresponding numbers of attributable cases, by age group and
sex, for seven cancer types accepted to be causally related to excess
body weight, assuming a 10-year latency between the presence of
excess body mass and cancer risk.
Table 4 summarises these results. An estimated 17294 excess in
cancer cases occurring in 2010 were due to overweight and obesity
(5.5% of all cancers). The sites contributing most to this excess are
large bowel (5172) and breast (4194).
DISCUSSION
The list of cancers that have been selected as being related to
excess body mass (overweight and obesity) is a conservative one. It
corresponds to those in the consensus statements of IARC (2002)
and WCRF (2007). Needless to say, other studies have identified a
large number of other cancers to be associated with excess body
mass. In the recent meta-analysis of prospective studies (cohort
studies and clinical trials) by Renehan et al (2008), there was a
positive (statistically significant) association between BMI and
cancer of the thyroid, leukaemia, malignant melanoma (men only),
non-Hodgkin lymphoma and multiple myeloma. Others have
reported significant associations with cancers of the prostate
(Bergstrom et al, 2001), ovary (Reeves et al, 2007; Schouten et al,
2008; Lahmann et al, 2010) and brain (Benson et al, 2008), as well
as cancers of the liver (Larsson and Wolk, 2007) and gastric cardia
(Calle and Kaaks, 2004).
In common with most reviews, we have chosen to ignore
possible differences in risk between men and women, although for
some cancers – especially colorectal cancers – a greater effect in
men than in women is found in some studies (Calle and Kaaks,
2004; Renehan et al, 2008) but not others (Bergstrom et al, 2001).
The 10-year ‘latency’ used to define the relevant time period at
which to measure population prevalence of overweight and obesity
is somewhat arbitrary. It was based on the average period of
follow-up in the large cohort studies from which the estimates of
relative risk are derived (as reported by Renehan et al, 2008).
Several previous estimates of the fraction of cancer in the UK
attributable to overweight and obesity have been published.
Bergstrom et al (2001) considered a similar range of cancers to
those in this paper, but included cancers of the prostate as related
to BMI, and excluded oesophageal adenocarcinoma; based on
relative risks from their own meta-analyses, they estimated that
2.7% of cancers diagnosed in men and 4.9% in women in the UK in
1995 were related to overweight/obesity during 1983–6. Renehan
et al (2010) include a much wider range of cancers, as noted
earlier, based on their meta-analysis of 2008 (Renehan et al, 2008);
their estimate of attributable fraction (for 2002, based on
overweight/obesity (single category) in 1992 (from WHO)) was
4.01% in women and 3.42% in men. Reeves et al (2007) used the
results of the Million Women Study to estimate that 5% of cancers
in postmenopausal women in 2004 were related to overweight and
obesity (based on prevalence in England in the same year), and
including nine cancers observed to have a significant trend of
increasing risk with increasing BMI (including leukaemia, ovary,
multiple myeloma and non-Hodgkin lymphoma, but excluding
colorectal cancers). The estimate of the proportion of cancers
related to ‘body fatness’ in the UK in 2002 by WCRF/AICR (2009)
is given only for the seven sites analysed in this paper: 18% of the
five cancers in men and 16% of the seven in women. This would be
equivalent to an overall AF (for all cancers) of 4.2% in men and
8.7% in women. There are several reasons for this larger estimate.
WCRF selected ‘representative’ studies from which to take the
relative risks – almost all are in excess of the pooled values from
their own meta-analyses. Exposure prevalence was taken from data
for the same year as outcome (2002); exposure prevalence would
have been lower if prevalence at an earlier period had been used,
given the continuously rising trend of overweight and obesity in
recent years. Finally, the baseline category (not overweight or
obese) was not always p25kgm
 2, but for some cancers (breast
and pancreas) it was p23kgm
 2.
See acknowledgements on page Si.
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